文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

糖原合成酶激酶-3β抑制剂对急性坏死性胰腺炎大鼠急性肾损伤的作用机制实验研究

[Experimental study on the mechanism of glycogen synthase kinase-3β inhibitor on acute kidney injury of acute necrotizing pancreatitis in rats].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2019-01-01
一句话结论大鼠实验中,GSK-3β抑制剂TDZD-8预处理可减轻急性坏死性胰腺炎相关肾损伤,机制涉及抑制NF-κB炎症信号通路。

该研究为动物实验,将SPF雄性Wistar大鼠随机分为假手术组、ANP模型组、TDZD-8干预组和TDZD-8对照组,每组20只。ANP模型通过胆管逆行注射5%牛磺胆酸钠制备;TDZD-8干预组和TDZD-8对照组于造模或假手术前30分钟经股静脉注射TDZD-8(1 mL/kg),ANP模型组和假手术组注射等量10%二甲基亚砜。术后12小时检测血清淀粉酶、脂肪酶、肌酐、尿素氮及炎症因子,并观察胰腺和肾脏病理及超微结构改变。结果显示,与ANP模型组相比,TDZD-8预处理显著降低血清淀粉酶、脂肪酶、肌酐、尿素氮及IL-1β、IL-6水平(均P<0.01),减轻胰腺和肾脏病理损伤及肾细胞超微结构损伤,减少NF-κBp65核表达,增加p-GSK-3β(Ser 9)表达,抑制TNF-α、ICAM-1、iNOS表达并增加IL-10表达。结论认为TDZD-8通过抑制NF-κB相关炎症介质对ANP相关肾损伤发挥保护作用。

要点

  • 大鼠ANP模型经胆管逆行注射5%牛磺胆酸钠制备,TDZD-8干预组于造模前30分钟经股静脉注射TDZD-8(1 mL/kg)。
  • 与ANP模型组相比,TDZD-8预处理组血清肌酐(μmol/L)47.38±1.48 vs 72.50±2.43,尿素氮(mmol/L)17.6±1.0 vs 26.0±1.0,均P<0.01。
  • 与ANP模型组相比,TDZD-8预处理组血清淀粉酶(kU/L)5.60±0.30 vs 10.07±0.34,脂肪酶(U/L)1 111.0±110.8 vs 2 375.0±51.1,均P<0.01。
  • 与ANP模型组相比,TDZD-8预处理组IL-1β(ng/L)195.90±5.50 vs 332.40±38.29,IL-6(ng/L)246.10±26.74 vs 385.30±32.19,均P<0.01。
  • TDZD-8预处理减轻胰腺和肾脏病理损伤(组织病理学评分7.1±0.4 vs 12.1±0.3,301.2±7.5 vs 433.5±13.8,均P<0.01)及肾细胞超微结构损伤。

适用人群与场景

  • SPF雄性Wistar大鼠,每组20只,随机分为假手术组、ANP模型组、TDZD-8干预组和TDZD-8对照组。

处置流程与药物剂量

  • TDZD-8干预组和TDZD-8对照组于造模或假手术前30分钟经股静脉注射GSK-3β抑制剂TDZD-8(1 mL/kg)。
  • ANP模型组和假手术组经股静脉注射等量10%二甲基亚砜(DMSO)。
  • ANP模型制备采用胆管逆行注射5%牛磺胆酸钠;假手术组胰腺管注射等量生理盐水。
  • 各组大鼠于术后12小时处死,检测血清淀粉酶、脂肪酶、肌酐、尿素氮及炎症因子,并观察胰腺和肾脏病理及超微结构。

研究设计与关键结果

  • 与假手术组相比,ANP模型组血清及炎症因子水平显著升高,胰腺和肾脏组织病理损伤严重,组织病理学评分显著升高,肾组织NF-κBp65核表达增强,GSK-3β、TNF-α、ICAM-1、iNOS表达显著增强,p-GSK-3β(Ser 9)和IL-10表达显著减弱。
  • 与ANP模型组相比,TDZD-8预处理显著降低血清淀粉酶(kU/L)5.60±0.30 vs 10.07±0.34、脂肪酶(U/L)1 111.0±110.8 vs 2 375.0±51.1、肌酐(μmol/L)47.38±1.48 vs 72.50±2.43、尿素氮(mmol/L)17.6±1.0 vs 26.0±1.0、IL-1β(ng/L)195.90±5.50 vs 332.40±38.29、IL-6(ng/L)246.10±26.74 vs 385.30±32.19,均P<0.01。
  • 与ANP模型组相比,TDZD-8预处理减轻胰腺和肾脏病理损伤(组织病理学评分7.1±0.4 vs 12.1±0.3,301.2±7.5 vs 433.5±13.8,均P<0.01)及肾细胞超微结构损伤。
  • 与ANP模型组相比,TDZD-8预处理组肾组织NF-κBp65核表达显著降低,p-GSK-3β(Ser 9)表达显著增加,TNF-α、ICAM-1、iNOS表达受抑制,IL-10表达增加;肾组织GSK-3β表达差异无统计学意义。
  • TDZD-8对照组与假手术组之间各指标差异无统计学意义。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,TDZD-8通过抑制GSK-3β活性阻断ANP中的炎症信号通路,从而对肾损伤发挥保护作用,减轻肾损伤的组织病理学和超微结构改变,该保护机制由NF-κB及其相关炎症介质介导。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the protective mechanism of glycogen synthase kinase-3β (GSK-3β) inhibitor TDZD-8 on acute necrotizing pancreatitis (ANP) associated kidney injury in rats.

METHODS: SPF male Wistar rats were randomly divided into four groups (n = 20): sham operation group (Sham group), ANP model group, TDZD-8 intervention group and TDZD-8 control group. The rat ANP model was prepared by retrograde injection of 5% sodium taurocholate into the bile duct; the same volume of normal saline was injected into the pancreatic duct of the Sham group. The TDZD-8 intervention group and the TDZD-8 control group were injected with GSK-3β inhibitor TDZD-8 (1 mL/kg) via the femoral vein 30 minutes before the model or sham operation; the ANP model group and the Sham group were injected equal volume of 10% dimethyl sulfoxide (DMSO). Rats in each group were sacrificed at 12 hours after operation to measure the serum amylase (AMY), blood lipase (LIPA), serum creatinine (SCr) and blood urea nitrogen (BUN) levels and to observe the pathological changes of pancreatic tissues and kidney tissues. Ultrastructural change of renal cells was analyzed by transmission electron microscopy. Serum interleukin-1β (IL-1β) and interleukin-6 (IL-6) levels were evaluated by enzyme linked immunosorbent assay (ELISA). The activation of nuclear factor-ΚBp65 (NF-ΚBp65) was evaluated by immunohistochemistry assay. The protein expressions of GSK-3β, phospho-GSK-3β (Ser 9), tumor necrosis factor-α (TNF-α), inducible nitric oxide synthase (iNOS), intercellular adhesion molecule-1 (ICAM-1) and interleukin-10 (IL-10) in the kidney were determined by Western Blot.

RESULTS: Compared with the Sham group, the serum and inflammatory factors levels of the ANP model group were significantly increased, the pathological damage of the pancreas and kidney tissues were severe, the histopathological score was significantly increased, the expression of NF-ΚBp65 was enhanced in the nucleus of the kidney tissue, and the expressions of GSK-3β, TNF-α, ICAM-1 and iNOS were significantly enhanced, and the expressions of p-GSK-3β(Ser 9) and IL-10 were significantly attenuated. Compared with the ANP model group, TDZD-8 pretreatment significantly reduced serum and inflammatory factor levels in the ANP model group [AMY (kU/L): 5.60±0.30 vs. 10.07±0.34, LIPA (U/L): 1 111.0±110.8 vs. 2 375.0±51.1, SCr (μmol/L): 47.38±1.48 vs. 72.50±2.43, BUN (mmol/L): 17.6±1.0 vs. 26.0±1.0, IL-1β (ng/L): 195.90±5.50 vs. 332.40±38.29, IL-6 (ng/L): 246.10±26.74 vs. 385.30±32.19, all P < 0.01]; pathological damage of pancreas and kidney tissue (histopathological score: 7.1±0.4 vs. 12.1±0.3, 301.2±7.5 vs. 433.5±13.8, both P < 0.01) and ultrastructural damage of renal cells were alleviated; the expression of NF-ΚBp65 in the nucleus was significantly decreased; the expression of p-GSK-3β (Ser 9) was significantly increased, and blocking GSK-3β activity could inhibit the expressions of TNF-α, ICAM-1, iNOS and increase the expression of IL-10, while the expression of GSK-3β in renal tissues was not statistically significant. There were no significant differences between the TDZD-8 control group and the Sham group.

CONCLUSIONS: Blockade of GSK-3β activity by TDZD-8 exerts the protective effect against kidney injury by inhibiting the inflammation signaling pathway in ANP. It can alleviate histopathological and ultrastructural changes in kidney injury, which protection mechanism is mediated by NF-ΚB and its related inflammatory mediators.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhao K, Yang X, Chen C, et al. [Experimental study on the mechanism of glycogen synthase kinase-3β inhibitor on acute kidney injury of acute necrotizing pancreatitis in rats]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31315730. doi:10.3760/cma.j.issn.2095-4352.2019.06.012

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。